Is Immunome Inc (IMNM) Stock About to Get Hot Friday?

Overall market sentiment has been high on Immunome Inc (IMNM) stock lately. IMNM receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Immunome Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on IMNM!

See Full IMNM Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With IMNM Stock Today?

Immunome Inc (IMNM) stock is up 6.21% while the S&P 500 is down -0.48% as of 1:56 PM on Friday, Oct 13. IMNM has risen $0.52 from the previous closing price of $8.38 on volume of 137,015 shares. Over the past year the S&P 500 is up 21.02% while IMNM has risen 78.36%. IMNM lost -$2.20 per share in the over the last 12 months. To screen for more stocks like Immunome Inc click here.

More About Immunome Inc

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The company's primary focus areas are oncology and infectious disease, including COVID-19. Click Here to get the full Stock Report for Immunome Inc stock.